TRANSCEND THERAPEUTICS
Summary
Transcend Therapeutics offers novel pharmaceuticals for the critical care market.
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 33 M
Avg. Deal Size£ 33 M
All rights reserved. Copyright © 2025 Datasite
Summary
Transcend Therapeutics offers novel pharmaceuticals for the critical care market.
Deals Overview
All rights reserved. Copyright © 2025 Datasite
Senior Management
Blake Mandell
Co-Founder and CEO
Ben Kelmendi
Co-Founder and Chief Scientific Advisor
Martin Stogniew
Chief Development Officer